Pharma-Funded 'Dark Money' Group Hosts House Staffers for California Junket
The staffers, several of whom work for reps on the subcommittee overseeing pharmaceuticals, met with executives from drug companies Merck and Genentech.
Page 86
Lawyers Defending ExxonMobil Are Big Biden Donors
Two of the Paul Weiss attorneys who successfully defended ExxonMobil in New York against charges that it hid costs related to climate change have given maximum donations to former Vice President Joe Biden.
🚨 SLUDGE REPORT SPECIAL: Billionaires Are...Actually Good For Democracy? 🚨
This special edition focuses on some interesting developments in the Democratic presidential primary.
Here Are the Lobbyists and Corporate Execs Collecting Checks for Pete Buttigieg
As the Buttigieg campaign stops releasing its bundler names and blocks press from fundraising events, here are some of the pharmaceutical and finance executives behind its rise in the big money race, and three attorneys whose donations were returned.
Conservative Democrat Gets $100k from Oil & Gas PACs in Bid to Fend Off Surging Progressive
Attorney Jessica Cisneros is taking on the fossil fuel-friendly Democratic Texas Rep. Henry Cuellar in the 2020 primary.
House Dems Try to Sneak Through Weak Financial Regulator Bill
The Commodity Futures Trading Commission is a critical derivatives regulator, and a House reauthorization fails to fortify it.
🚨SLUDGE REPORT: Pay-to-Play Ambassadorships🚨
Your regular summary of the most shameful corruption in politics.
Support Sludge on #GivingTuesday
A Sludge reader saw our funding situation and contacted us with a generous offer to match up to $5,000 in new donations.
After Meeting With Pharma-Backed Rep, Trump Flip-Flops on Drug Price Negotiations
After Rep. Greg Walden, the biggest recipient of pharmaceutical campaign cash in the last election cycle, met with Trump, the president decided to scrap his support for lower drug prices.
DLCC Set Up One-On-One Meetings for Lobbyists and Lawmakers at Summer Conference
Documents reveal that over 140 lobbyists representing oil, pharma, insurance, and other industries scored one-on-one meetings with state legislative leaders.